A rumor regarding Viking Therapeutics (VKTX) was highlighted in an alert sent to subscribers of Ben Harrington’s takeover-focused Betaville blog, contacts tell The Fly.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- Target downgraded, Cisco upgraded: Wall Street’s top analyst calls
- Scotiabank starts Viking Therapeutics at Outperform, sees attractive entry point
- Viking Therapeutics initiated with an Outperform at Scotiabank
- Viking Therapeutics price target lowered to $95 from $120 at Truist
- Roblox downgraded, Pinterest upgraded: Wall Street’s top analyst calls